Whitney & Co’s West Pharmaceutical WST Stock Holding History

Whitney & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12	Closed	-$1K	–	475
2018 Q3	$1K	Buy	+12	New	+$1.35K	﹤0.01%	521

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Whitney & Co's WST Position: Q4 2018 in Review

Whitney & Co sold out of West Pharmaceutical (WST) in Q4 2018, closing a stake of 12 shares — an estimated $1K sold.

Whitney & Co first reported a position in WST in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

Whitney & Co reported no remaining West Pharmaceutical position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 12 West Pharmaceutical shares in Q4 2018, an estimated $1K.
Whitney & Co first reported a position in West Pharmaceutical in Q3 2018 and held it in 1 quarter.
Whitney & Co's West Pharmaceutical position peaked at $1K in Q3 2018.
355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.